EMCN and breast cancer: MUC14 expression was markedly decreased in breast cancer with specific clinicopathological characteristics, such as TNBC, basal-like breast cancer, P53 mutated breast cancer, advanced SBR grade and NPI score, further suggesting that MUC14 might act as a tumor suppressor in breast cancer.